Home | News | Commentary | The Mutating Virus

The Mutating Virus

By Staff Reporter

January 28, 2021
11:15 pm
Los Angeles, CA

Since COVID-19 emerged from the mainland Chinese city of Wuhan, many have speculated that it is in fact a biological weapon that escaped from a lab as oppose to the official narrative of its emergence from a Chinese wet market. Suspiciously, even a year after the outbreak, the Chinese Communist government has refused international requests for onsite investigations into the origin of the virus. Are they trying to hide something? In a tragic tale that is now taking a turn for the worse, it appears that the COVID-19 virus is rapidly mutating, as if by design, even as potential vaccines are being introduced to the global public on a mass scale. Recent mutations from the United Kingdom, South Africa, and Brazil are causing the public to question whether the

Suspiciously, even a year after the outbreak, the Chinese Communist government has refused international requests for onsite investigations into the origin of the virus. Are they trying to hide something?

In a tragic tale that is now taking a turn for the worse, it appears that the COVID-19 virus is rapidly mutating, as if by design, even as potential vaccines are being introduced to the global public on a mass scale. Recent mutations from the United Kingdom, South Africa, and Brazil are causing the public to question whether the two current vaccines that are available will even be remotely effective.

Medic with mask works on a solution for covid 19 virus. Concept of medical research (Photo:Dreamstime/Alphaspirit)

A recent study at Rockefeller University in New York obtained blood samples from 20 people who had received either the Moderna or Pfizer vaccine and tested their antibodies against various virus mutations in the lab.

With some of the samples, the antibodies didn’t work against the new virus mutations, with activity being one to threefold less depending on the mutation. The study’s leader, Dr. Michel Nussenzweig, went on to state however that: “We don’t want people thinking that the current vaccine is already outdated. That’s absolutely not true,” he said. “There’s still immunity here … a good level of protection,” but the mutations “do in fact reduce how well our immune response is recognizing the virus.”

When one expert, John Brooks, the chief medical officer at the Centers for Disease Control’s COVID-19 Emergency Response, was questioned about the best way to fight the mutations he stated that: “The best way is to suppress replication…and that means stopping infections. It’s a race…We’ve got to get people vaccinated before more of these mutations occur.”

But can this “race” to vaccinate the world before new mutations occur be realistically achieved?

The logistical challenge is daunting enough, but there are also mounting voices of skepticism, and concern. Many of the new vaccines, like Pfizer, BioNtech, and Moderna, rely on messenger RNA or mRNA, a very new technology.

Though “official experts” have said these mRNA vaccines cannot genetically modify humans, “official experts” have also lost considerable faith from the public in recent times. For example, it was reported by the Epoch Times that a Wisconsin hospital pharmacist told police that he intentionally attempted to destroy hundreds of COVID-19 vaccine doses because he thought the shots would alter or mutate people’s DNA, according to court documents.

As new variants reveal themselves across the globe, will still newer vaccines be needed? At what point should people draw the line?

The Center for Disease Control has predicted that B.1.1.7, a new mutant COVID-19 strain emerging from the United Kingdom, will be the predominant variant in the United States by early spring. Hospitals are being warned to expect another surge, which will outpace the immunization process now underway.

This aggressive new variant began circulating in southeast England, and last October, local authorities announced a monthlong lockdown. The lockdown was successful in curbing the spread of COVID-19 in other parts of the country, but not specifically in the Kent corridor, the epicenter for the new mutation B.1.1.7.

Experts have speculated that it takes less of this new mutant strain to infect an individual due to its larger viral load, and that it appears to spread more rapidly. Experts have also observed B.1.1.7 quickly spreading to dozens of other countries. What is most baffling to scientists, however, is the fact that these new mutant strains don’t appear to be more fatal despite the increased viral load and susceptibility to infection.

Perhaps it’s just a matter of time before a much more deadly version of this virus emerges? Only time will tell.